Madhavbaug Posts H1 FY27 Net Loss of ₹1.60 Cr vs Profit of ₹3.22 Cr YoY; Revenue Dips to ₹46.36 Cr
Vaidya Sane Ayurved Laboratories reported standalone revenue from operations of ₹46.36 crore for the half year ended September 30, 2026, down 1.75% from ₹47.19 crore in H1 FY26. The company swung to a net loss of ₹1.60 crore from a profit of ₹3.22 crore in the corresponding previous period, largely driven by a sharp jump in other expenses to ₹26.59 crore (up from ₹19.50 crore). Diluted EPS slipped into negative territory at -₹1.52 compared to ₹1.41 in H1 FY26. Short-term borrowings also expanded sharply to ₹11.82 crore as of September 30, 2026, compared to ₹2.59 crore at the end of March 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company reported its unaudited standalone and consolidated H1 FY27 results, swinging from profit to a net loss alongside an increase in short-term borrowing levels.
ஏன் இது முக்கியம்Higher operating expenses and elevated marketing costs directly compressed profitability, reversing recent positive earnings momentum despite a low debt base.
Revenue from operations (H1 FY27): ₹4,635.71 லட்சம்Net Profit / Loss (H1 FY27): -₹159.81 lakhOther expenses (H1 FY27): ₹2,659.15 லட்சம்Short-term borrowings (Sep 30, 2026): ₹1,182.34 லட்சம்Basic EPS (H1 FY27): -1.52
📅 குறுகிய காலம்Negative sentiment is likely over coming weeks as investors digest the swing into net losses and an increase in working capital debt.
📈 நீண்ட காலம்Long-term trajectory depends on stabilizing customer acquisition unit economics, successfully commercializing Madhavprash, and driving higher clinic utilization.
⚠ அபாய எச்சரிக்கைகள்
- Surge in other expenses eroding operating margins
- Significant rise in short-term borrowings from ₹2.59 cr to ₹11.82 cr
- Auditor noted unverified MSME classification and lack of provision for potential delayed-payment interest
👀 கவனிக்க வேண்டியவை
Track the drivers behind the surge in other expenses (such as digital customer acquisition spend) and monitor whether clinic utilization recovers to stem further operating losses in H2 FY27.
